← Back to Clinical Trials
Recruiting NCT07455344

NCT07455344 Mechanisms and Outcomes of Children and Adolescent Psychotherapy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07455344
Status Recruiting
Phase
Sponsor Shalvata Mental Health Center
Condition Mental Health
Study Type OBSERVATIONAL
Enrollment 30,000 participants
Start Date 2025-01-05
Primary Completion 2027-01-30

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30,000 participants in total. It began in 2025-01-05 with a primary completion date of 2027-01-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Since October 7th 2023, Israel's population has been forced to engage in a multi-regional war which affected most of the citizens of Israel. One of the most sensitive populations to be affected by the horrifying events are children and adolescents. In a meta-analysis summarizing the results of 20 studies encompassing a total of 26,302 children and adolescents, the authors reported a significant association between the degree of exposure to traumatic events and psychological distress (Slone et al., 2017). Furthermore, a recent study conducted in Ukraine during Russia's invasion indicated an increase in internalizing symptoms among children and adolescents, as reported by parents (McElroy et al., 2024). Nevertheless, to date, no study has evaluated the extent of distress, and overall mental and physical consequences among children and their parents, in the context of the October 7th events. One of the main routes to provide care to children and adolescents inflicted by the consequences of war is through psychotherapy. Although psychotherapy is considered an effective treatment for children and adolescents, studies indicate that dropout rates among this population is as high as 45% (De Haan et al., 2013). Several predictors were previously offered to be associated with children and adolescents' dropout and psychotherapy outcomes. These predictors can be broadly categorized into two conceptual dimensions. The first is pre-treatment variables that are associated with both children and their parents, such as demographics (i.e., ethnicity, gender, age), diagnosis (including classification and co-morbidity), symptom severity, family characteristics, and parental problems and difficulties (De Soet et al., 2023; Skar et al., 2022). The second dimension is related to within-therapy factors, such as patients' expectations and the quality of mutual work with the therapist (O'Keeffe et al., 2018). Nonetheless, to date, no systematic study has assessed pre-treatment and within-treatment predictors of dropout and outcome in general or in the context of political conflict. Research Objectives This study aims to address current gaps in the literature by assessing the effects of October 7th events on parents, children, and adolescents. Furthermore, the study aims to assess the effects of psychotherapy provided in the settings of crisis intervention and treatment as usual in outpatient clinics to children following the war. Research objectives will be addressed using two methodological approaches: a retrospective big-data strategy exploration, and a prospective assessment of ongoing psychotherapies. Based on the reviewed literature, the following research hypotheses will be investigated: 1. Parental psychopathology will mediate the association between traumatic exposure during war and their child's mental and physical health. 2. Dropout rates from psychotherapy in Israel will be found as similar to those reported in a previous meta-analysis (\~45%) (De Haan et al., 2013). 3. Within-treatment variables will have a stronger association with dropout risk and outcome, compared to pre-treatment variables.

Eligibility Criteria

Study 1: Inclusion criteria will be children and adolescents who participated in outpatient psychotherapy in CHS databases. Exclusion Criteria: Participants will be excluded in case of mental or physical hospitalization during psychotherapy. Study 2: Inclusion criteria for patients and caregivers include participation in psychotherapy in the Crisis Intervention Unit in Shalvata MHC. Inclusion criteria for therapists will be as follows (1) a professional license to practice psychotherapy (2) conducting psychotherapy in the child and adolescent clinic in Shalvata MHC. Patients and caregivers will be excluded in case of not being able to or willing to sign informed consent, or if there is an immediate risk, as evaluated by the treating physician.

Contact & Investigator

Central Contact

Prof. Dana Tzur-Bitan, Prof

✉ Dana.tzur@gmail.com

📞 +972542300966

Frequently Asked Questions

Who can join the NCT07455344 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, studying Mental Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07455344 currently recruiting?

Yes, NCT07455344 is actively recruiting participants. Contact the research team at Dana.tzur@gmail.com for enrollment information.

Where is the NCT07455344 trial being conducted?

This trial is being conducted at Hod HaSharon, Israel.

Who is sponsoring the NCT07455344 clinical trial?

NCT07455344 is sponsored by Shalvata Mental Health Center. The trial plans to enroll 30,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology